Global Oncology Nutrition Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Oncology Nutrition Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Oncology Nutrition Market Size Growth Rate by Product
- 1.4.2 Milk Based
- 1.4.3 Soy Based
- 1.4.4 Organic
- 1.4.5 Probiotic
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Oncology Nutrition Market Size Growth Rate by End User
- 1.5.2 Esophageal Cancer
- 1.5.3 Lung Cancer
- 1.5.4 Breast Cancer
- 1.5.5 Blood Cancer
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oncology Nutrition Market Size
- 2.1.1 Global Oncology Nutrition Revenue 2014-2025
- 2.1.2 Global Oncology Nutrition Sales 2014-2025
- 2.2 Oncology Nutrition Growth Rate by Regions
- 2.2.1 Global Oncology Nutrition Sales by Regions
- 2.2.2 Global Oncology Nutrition Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Oncology Nutrition Sales by Manufacturers
- 3.1.1 Oncology Nutrition Sales by Manufacturers
- 3.1.2 Oncology Nutrition Sales Market Share by Manufacturers
- 3.1.3 Global Oncology Nutrition Market Concentration Ratio (CR5 and HHI)
- 3.2 Oncology Nutrition Revenue by Manufacturers
- 3.2.1 Oncology Nutrition Revenue by Manufacturers (2014-2019)
- 3.2.2 Oncology Nutrition Revenue Share by Manufacturers (2014-2019)
- 3.3 Oncology Nutrition Price by Manufacturers
- 3.4 Oncology Nutrition Manufacturing Base Distribution, Product Types
- 3.4.1 Oncology Nutrition Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oncology Nutrition Product Type
- 3.4.3 Date of International Manufacturers Enter into Oncology Nutrition Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Oncology Nutrition Sales by Product
- 4.2 Global Oncology Nutrition Revenue by Product
- 4.3 Oncology Nutrition Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Oncology Nutrition Breakdown Data by End User
6 North America
- 6.1 North America Oncology Nutrition by Countries
- 6.1.1 North America Oncology Nutrition Sales by Countries
- 6.1.2 North America Oncology Nutrition Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Oncology Nutrition by Product
- 6.3 North America Oncology Nutrition by End User
7 Europe
- 7.1 Europe Oncology Nutrition by Countries
- 7.1.1 Europe Oncology Nutrition Sales by Countries
- 7.1.2 Europe Oncology Nutrition Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oncology Nutrition by Product
- 7.3 Europe Oncology Nutrition by End User
8 Asia Pacific
- 8.1 Asia Pacific Oncology Nutrition by Countries
- 8.1.1 Asia Pacific Oncology Nutrition Sales by Countries
- 8.1.2 Asia Pacific Oncology Nutrition Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Oncology Nutrition by Product
- 8.3 Asia Pacific Oncology Nutrition by End User
9 Central & South America
- 9.1 Central & South America Oncology Nutrition by Countries
- 9.1.1 Central & South America Oncology Nutrition Sales by Countries
- 9.1.2 Central & South America Oncology Nutrition Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Oncology Nutrition by Product
- 9.3 Central & South America Oncology Nutrition by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Oncology Nutrition by Countries
- 10.1.1 Middle East and Africa Oncology Nutrition Sales by Countries
- 10.1.2 Middle East and Africa Oncology Nutrition Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Oncology Nutrition by Product
- 10.3 Middle East and Africa Oncology Nutrition by End User
11 Company Profiles
- 11.1 Abbott Laboratories (US)
- 11.1.1 Abbott Laboratories (US) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Abbott Laboratories (US) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Abbott Laboratories (US) Oncology Nutrition Products Offered
- 11.1.5 Abbott Laboratories (US) Recent Development
- 11.2 Nestle S.A. (Switzerland)
- 11.2.1 Nestle S.A. (Switzerland) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Nestle S.A. (Switzerland) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Nestle S.A. (Switzerland) Oncology Nutrition Products Offered
- 11.2.5 Nestle S.A. (Switzerland) Recent Development
- 11.3 Danone (France)
- 11.3.1 Danone (France) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Danone (France) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Danone (France) Oncology Nutrition Products Offered
- 11.3.5 Danone (France) Recent Development
- 11.4 Fresenius Kabi AG (Germany)
- 11.4.1 Fresenius Kabi AG (Germany) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Fresenius Kabi AG (Germany) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Fresenius Kabi AG (Germany) Oncology Nutrition Products Offered
- 11.4.5 Fresenius Kabi AG (Germany) Recent Development
- 11.5 B.Braun Melsungen AG (Germany)
- 11.5.1 B.Braun Melsungen AG (Germany) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 B.Braun Melsungen AG (Germany) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 B.Braun Melsungen AG (Germany) Oncology Nutrition Products Offered
- 11.5.5 B.Braun Melsungen AG (Germany) Recent Development
- 11.6 Mead Johnson Nutrition Company (US)
- 11.6.1 Mead Johnson Nutrition Company (US) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Mead Johnson Nutrition Company (US) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Mead Johnson Nutrition Company (US) Oncology Nutrition Products Offered
- 11.6.5 Mead Johnson Nutrition Company (US) Recent Development
- 11.7 Hormel Foods (US)
- 11.7.1 Hormel Foods (US) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Hormel Foods (US) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Hormel Foods (US) Oncology Nutrition Products Offered
- 11.7.5 Hormel Foods (US) Recent Development
- 11.8 Meiji Holdings (Japan)
- 11.8.1 Meiji Holdings (Japan) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Meiji Holdings (Japan) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Meiji Holdings (Japan) Oncology Nutrition Products Offered
- 11.8.5 Meiji Holdings (Japan) Recent Development
- 11.9 Victus (US)
- 11.9.1 Victus (US) Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Victus (US) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Victus (US) Oncology Nutrition Products Offered
- 11.9.5 Victus (US) Recent Development
- 11.10 Global Health Products (US)
- 11.10.1 Global Health Products (US) Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Global Health Products (US) Oncology Nutrition Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Global Health Products (US) Oncology Nutrition Products Offered
- 11.10.5 Global Health Products (US) Recent Development
12 Future Forecast
- 12.1 Oncology Nutrition Market Forecast by Regions
- 12.1.1 Global Oncology Nutrition Sales Forecast by Regions 2019-2025
- 12.1.2 Global Oncology Nutrition Revenue Forecast by Regions 2019-2025
- 12.2 Oncology Nutrition Market Forecast by Product
- 12.2.1 Global Oncology Nutrition Sales Forecast by Product 2019-2025
- 12.2.2 Global Oncology Nutrition Revenue Forecast by Product 2019-2025
- 12.3 Oncology Nutrition Market Forecast by End User
- 12.4 North America Oncology Nutrition Forecast
- 12.5 Europe Oncology Nutrition Forecast
- 12.6 Asia Pacific Oncology Nutrition Forecast
- 12.7 Central & South America Oncology Nutrition Forecast
- 12.8 Middle East and Africa Oncology Nutrition Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oncology Nutrition Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
The global Oncology Nutrition market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oncology Nutrition market based on company, product type, end user and key regions.
This report studies the global market size of Oncology Nutrition in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oncology Nutrition in these regions.
This research report categorizes the global Oncology Nutrition market by top players/brands, region, type and end user. This report also studies the global Oncology Nutrition market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories (US)
Nestle S.A. (Switzerland)
Danone (France)
Fresenius Kabi AG (Germany)
B.Braun Melsungen AG (Germany)
Mead Johnson Nutrition Company (US)
Hormel Foods (US)
Meiji Holdings (Japan)
Victus (US)
Global Health Products (US)
Market size by Product
Milk Based
Soy Based
Organic
Probiotic
Others
Market size by End User
Esophageal Cancer
Lung Cancer
Breast Cancer
Blood Cancer
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Oncology Nutrition market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oncology Nutrition market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oncology Nutrition companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oncology Nutrition submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Oncology Nutrition are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oncology Nutrition market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.